On the occasion of the Cochlear Implant Symposium in Geneva in October 1991, top hearing results attained by a young postlingually deaf woman with cochlear implant systems were presented in video recordings. These data are centered on demanding hearing performances in test situations and in a telephone conversation. For various reasons, two reimplantations were necessary in this deaf patient. Initially, she was provided with a single-channel extracochlear electrode of the Vienna type, which she found to improve her lipreading substantially, and she attained an unexpectedly good understanding of speech on a purely auditory basis. Today, this postlingually deaf women uses a multichannel intracochlear electrode of the Nucleus type. The excellent results with the first extracochlear system are clearly surpassed with the intracochlear system. Not least because of her above-average speech competence, the cochlear implant user attains a high degree of open speech understanding. Her verbal hearing efficiency is comparable to that of a person with mild to moderately severe hearing loss.

Keywords:
Cochlear implant, Single-channel extracochlear electrode, Intracochlear multichannel electrode, Cochlear reimplantation
This content is only available via PDF.
© 1992 S. Karger AG, Basel
1992
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.